Trial Profile
Treatment of diabetic nephropathy
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 25 Jan 2010
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 22 Oct 2005 New trial record.